Sensus Healthcare Inc (NASDAQ:SRTS) has a beta value of 1.21 and has seen 0.27 million shares traded in the last trading session. The company, currently valued at $90.31M, closed the last trade at $5.51 per share which meant it gained $0.01 on the day or 0.18% during that session. The SRTS stock price is -69.33% off its 52-week high price of $9.33 and 47.19% above the 52-week low of $2.91. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.81 million shares traded. The 3-month trading volume is 356.11K shares.
The consensus among analysts is that Sensus Healthcare Inc (SRTS) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 3 have rated it as a Hold, with 3 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.05.
Sensus Healthcare Inc (NASDAQ:SRTS) trade information
Sporting 0.18% in the green in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the SRTS stock price touched $5.51 or saw a rise of 13.23%. Year-to-date, Sensus Healthcare Inc shares have moved -20.38%, while the 5-day performance has seen it change -5.57%. Over the past 30 days, the shares of Sensus Healthcare Inc (NASDAQ:SRTS) have changed -18.61%. Short interest in the company has seen 1.55 million shares shorted with days to cover at 6.49.
Wall Street analysts have a consensus price target for the stock at $10, which means that the shares’ value could jump 44.9% from current levels. The projected low price target is $10.0 while the price target rests at a high of $10.0. In that case, then, we find that the current price level is -81.49% off the targeted high while a plunge would see the stock gain -81.49% from current levels.
Sensus Healthcare Inc (SRTS) estimates and forecasts
The company’s shares have lost -10.84% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 6.96%.
5 analysts offering their estimates for the company have set an average revenue estimate of 7.75M for the current quarter. 5 have an estimated revenue figure of 9.66M for the next ending quarter. Year-ago sales stood 10.66M and 9.24M respectively for this quarter and the next, and analysts expect sales will shrink by -27.36% for the current quarter and 6.96% for the next. Earnings growth for 2025 is a modest 1.95% while over the next 5 years, the company’s earnings are expected to increase by 11.61%.
SRTS Dividends
Sensus Healthcare Inc is expected to release its next earnings report in March this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Sensus Healthcare Inc (NASDAQ:SRTS)’s Major holders
Insiders own 17.75% of the company shares, while shares held by institutions stand at 30.45% with a share float percentage of 37.01%. Investors are also buoyed by the number of investors in a company, with Sensus Healthcare Inc having a total of 83.0 institutions that hold shares in the company. The top two institutional holders are VANGUARD GROUP INC with over 0.78 million shares worth more than $4.15 million. As of 2024-06-30, VANGUARD GROUP INC held 4.7809% of shares outstanding.
The other major institutional holder is RENAISSANCE TECHNOLOGIES LLC, with the holding of over 0.39 million shares as of 2024-06-30. The firm’s total holdings are worth over $2.09 million and represent 2.4028% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. As of Sep 30, 2024 , the former fund manager holds about 3.39% shares in the company for having 555.56 shares of worth $3.06 million while later fund manager owns 207.42 shares of worth $1.14 million as of Sep 30, 2024 , which makes it owner of about 1.27% of company’s outstanding stock.
